Showing results (431-440 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|May 22, 2018
Comparisons of false negative rates from a trend test alone and from a trend test jointly with a control-high groups pairwise test in the determination of the carcinogenicity of new drugsKarl K Lin, Mohammad A RahmanJournal of Biopharmaceutical Statistics|June 29, 2018
Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studiesGetachew A DagneJournal of Biopharmaceutical Statistics|June 29, 2018
L-statistics of absolute differences for quantifying the agreement between two variablesElahe Tashakor, Vernon M ChinchilliJournal of Biopharmaceutical Statistics|July 4, 2018
Quantitative decision-making in randomized Phase II studies with a time-to-event endpointBo Huang, Enayet Talukder, Lixin Han, et al.Journal of Biopharmaceutical Statistics|November 11, 2005
Tests for equivalence based on odds ratio for matched-pair designJen-Pei Liu, Hsin-Yi Fan, Mi-Chia MaJournal of Biopharmaceutical Statistics|November 11, 2005
Estimation of cancer drug potencies and relative potencies from in vitro dataT Le Chap, Patricia M Grambsch, An LiuJournal of Biopharmaceutical Statistics|November 11, 2005
Maximum likelihood estimation in survival studies under progressive interval censoring with random removalsLiming Xiang, Siu Keung TseJournal of Biopharmaceutical Statistics|August 26, 2016
Issues in developing multivariable molecular signatures for guiding clinical care decisionsMichael C Sachs, Lisa M McShaneJournal of Biopharmaceutical Statistics|May 20, 2014
Testing equality and interval estimation in binary responses when high dose cannot be used first under a three-period crossover designKung-Jong Lui, Kuang-Chao ChangPageof 216